Bayer Aktiengesellschaft: Number of Employees 2010-2024 | BAYRY

Interactive chart of Bayer Aktiengesellschaft (BAYRY) annual worldwide employee count from 2010 to 2024.
  • Bayer Aktiengesellschaft total number of employees in 2023 was 99,723, a 1.62% decline from 2022.
  • Bayer Aktiengesellschaft total number of employees in 2022 was 101,369, a 1.74% increase from 2021.
  • Bayer Aktiengesellschaft total number of employees in 2021 was 99,637, a 0.1% increase from 2020.
  • Bayer Aktiengesellschaft total number of employees in 2020 was 99,538, a 4.13% decline from 2019.
Bayer Aktiengesellschaft Annual Employee Count
2023 99,723
2022 101,369
2021 99,637
2020 99,538
2019 103,824
2018 110,838
2017 99,820
2016 115,200
2015 116,800
2014 118,888
2013 113,200
2012 110,500
2011 111,800
2010 111,400
2009
Sector Industry Market Cap Revenue
Medical Large Cap Pharma $22.635B $51.553B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Eli Lilly and Company (LLY) US $828.397B 67.21
Novo Nordisk A/S (NVO) DK $395.262B 26.77
Johnson & Johnson (JNJ) US $390.756B 16.25
AbbVie Inc. (ABBV) US $356.743B 19.97
Roche Holding AG (RHHBY) CH $264.174B 0.00
Merck & Co., Inc. (MRK) US $226.402B 11.72
Novartis AG (NVS) CH $223.511B 14.00
Pfizer Inc. (PFE) US $149.042B 8.46
Sanofi (SNY) $138.211B 13.09
Innoviva, Inc. (INVA) US $1.132B 9.42